Oncology is the largest pharma market and among most competitive. Despite huge progress, large unmet medical needs remain.
Increasingly expensive treatments - check-point inhibitors, CAR-T, mRNA..., and complex decision making, require a high-end, value-based, omni-channel go-to-market model
